Dr. Scott E. Evans, MD

Dr. Evans practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Evans' NPI, 1396844460, was assigned on September 22, 2006. Dr. Evans graduated from Joe R. & Teresa Lozano Long School of Medicine in 1999. Dr. Evans holds Texas license M1662.

Dr. Evans' primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Evans' primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Evans practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Evans' primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Evans is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Evans' licenses on file in 11 states: Texas, Florida, Georgia, Arizona, Louisiana, Tennessee, Washington, Alabama, Mississippi, Oklahoma and Minnesota.

Dmand AI lists chronic obstructive pulmonary disease (COPD), pneumonia, pulmonary fibrosis and tobacco use among the conditions Dr. Evans treats.

CMS data shows 158 Medicare services from Dr. Evans across 7 procedure codes in 2024, for 115 Medicare patients. Medicare paid $8,096 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 115 Medicare patients who saw Dr. Evans in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Evans' median patient age at 70, with 58% women.

In 2024, Dr. Evans wrote 42 Medicare Part D claims for 13 patients. 55% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $5,503 in total drug cost. In 2018, CMS named 37 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Evans for performance year 2024, reported as part of a group. Dr. Evans accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 108 papers to Dr. Evans, published from 2008 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Pneumonia, Lung and Immunity, Innate. Dr. Evans has published most often in Ann Am Thorac Soc. Dr. Evans' most frequent co-authors are Burton F. Dickey, MD, Ajay Sheshadri, MD and Dimitrios P. Kontoyiannis, MD.

CMS Open Payments shows 5 general payments to Dr. Evans from 2 drug and device companies from 2019 to 2023. Consulting fees make up the largest share, 88% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,680.

Dr. Evans graduated from Joe R. & Teresa Lozano Long School of Medicine in 1999. Dr. Evans is a member of ACP.

Dr. Evans is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.